Eosinophilic granulomatosis with polyangiitis present and future

Rheumatology (Oxford). 2021 Jun 17;60(Suppl 3):iii24-iii27. doi: 10.1093/rheumatology/keab033.

Authors

Federica Mescia^{1

2}, Allyson C Egan^{1

2}, Kim Cheema³, Pasupathy Sivasothy², David R W Jayne^{1

2}

Affiliations

¹ Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
² Vasculitis and Lupus Unit, Department of Medicine, Addenbrooke's Hospital, Cambridge, UK.
³ Cummings School of Medicine, University of Calgary, Alberta, Canada.

PMID: 34137880
DOI: 10.1093/rheumatology/keab033

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Antibodies, Monoclonal, Humanized / therapeutic use
Eosinophilic Granuloma / diagnosis*
Eosinophilic Granuloma / drug therapy
Female
Glucocorticoids / therapeutic use
Granulomatosis with Polyangiitis / diagnosis*
Granulomatosis with Polyangiitis / drug therapy
Humans
Immunosuppressive Agents / therapeutic use
Prednisolone / therapeutic use

Substances

Antibodies, Monoclonal, Humanized
Glucocorticoids
Immunosuppressive Agents
mepolizumab
Prednisolone